Presentation is loading. Please wait.

Presentation is loading. Please wait.

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer  Alessandro Brunelli, MD, Michele.

Published byMichael Nelson Modified over 5 years ago

Similar presentations

Presentation on theme: "Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer  Alessandro Brunelli, MD, Michele."— Presentation transcript:

1 Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer  Alessandro Brunelli, MD, Michele Salati, MD, Majed Refai, MD, Francesco Xiumé, MD, Rossana Berardi, MD, Paola Mazzanti, MD, Cecilia Pompili, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 146, Issue 2, Pages e2 (August 2013) DOI: /j.jtcvs Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Kaplan-Meier estimates of overall survival in all patients with non–small cell lung cancer, according to different survival aggregate scores (log-rank test, P < .0001). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Kaplan-Meier estimates of cancer-specific survival in all patients, according to different survival aggregate scores (log-rank test, P < .0001). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

4 Figure E1 Kaplan-Meier estimates of overall survival in patients with pT1 stage non–small cell lung cancer, according to different survival aggregate scores (log-rank test, P = .01). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

5 Figure E2 Kaplan-Meier estimates of overall survival in patients with pT2 stage non–small cell lung cancer, according to different survival aggregate scores (log-rank test, P = .02). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

6 Figure E3 Kaplan-Meier estimates of overall survival in patients with pT1-2 N0 stage non–small cell lung cancer, according to different survival aggregate scores (log-rank test, P = .0005). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

7 Figure E4 Kaplan-Meier estimates of overall survival in patients with pT1-2 N1-2 stage non–small cell lung cancer, according to different survival aggregate scores (log-rank test, P = .02). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

8 Figure E5 Kaplan-Meier estimates of overall survival in patients with pT1 N0 stage non–small cell lung cancer, according to different survival aggregate scores (log-rank test, P = .04). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

9 Figure E6 Kaplan-Meier estimates of overall survival in patients with pT2 N0 stage non–small cell lung cancer, according to different survival aggregate scores (log-rank test, P = .1). SAS, Survival aggregate score. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer  Alessandro Brunelli, MD, Michele."

Similar presentations

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.

Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data  Chris R. Kelsey, MD, Kristin.

Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data  Chris R. Kelsey, MD, Kristin.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer  Marco Alifano, MD, PhD, Pierre.

Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer  Marco Alifano, MD, PhD, Pierre.
Lung cancer screening: No more excuses

Lung cancer screening: No more excuses
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer  Keiju Aokage, MD, Junji Yoshida,

The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer  Keiju Aokage, MD, Junji Yoshida,
The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation  Arman Kilic, MD,

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation  Arman Kilic, MD,
Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients 

Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients 
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Similar presentations

Ads by Google